BARCLAYS PLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$39
-15.2%
50,0610.0%0.00%
Q2 2023$46
-100.0%
50,061
-85.3%
0.00%
Q3 2022$366,000
-14.9%
340,068
+34.6%
0.00%
Q2 2022$430,000252,682
+2297009.1%
0.00%
Q3 2021$011
-77.6%
0.00%
Q2 2021$0
-100.0%
49
-99.4%
0.00%
Q1 2021$43,0000.0%8,189
+2.5%
0.00%
Q4 2020$43,000
-27.1%
7,988
+7.9%
0.00%
Q3 2020$59,000
-20.3%
7,4000.0%0.00%
Q2 2020$74,000
+270.0%
7,4000.0%0.00%
Q1 2020$20,000
+1900.0%
7,400
+1306.8%
0.00%
Q4 2019$1,000
-50.0%
526
-68.0%
0.00%
Q3 2019$2,000
-50.0%
1,643
+88.6%
0.00%
Q1 2019$4,000
+100.0%
871
+221.4%
0.00%
Q4 2018$2,000
+100.0%
271
+367.2%
0.00%
Q3 2018$1,000
-99.8%
58
-99.8%
0.00%
Q2 2018$417,000
+3.5%
35,111
-2.3%
0.00%
Q1 2018$403,000
+72.2%
35,951
+2.4%
0.00%
Q4 2017$234,000
-24.0%
35,100
-6.6%
0.00%
Q3 2017$308,00037,6000.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$1,501,2502.44%
NEA Management Company, LLC 17,079,779$18,616,9581.29%
Endurant Capital Management LP 1,660,835$1,810,3100.93%
Matrix Capital Management Company, LP 38,974,185$42,481,8620.58%
Long Focus Capital Management, LLC 5,435,439$5,924,6290.34%
PFM Health Sciences, LP 5,992,571$6,531,9020.29%
Key Client Fiduciary Advisors, LLC 321,155$350,0590.22%
DAFNA Capital Management LLC 351,064$382,6600.12%
Rock Springs Capital Management LP 2,787,845$3,038,7510.07%
Baker Brothers Advisors 9,830,877$10,715,6560.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders